|Peer-Reviewed|December 23, 2020

January 2021
Volume 27
Issue 1

Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Author(s)Brenna L. Brady, PhD, Matthew Lucci, MPH, Kathleen Wilson, MPH

Supplemental materials for article examining the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.

eAPPENDIX Chemotherapy-Induced Peripheral Neuropathy in mBC

Articles in this issue

about 5 years ago

Article

ASH 2020: Clinical Updates

about 5 years ago

Article

ASH 2020: COVID-19 and Hematology

about 5 years ago

Article

ASH 2020: CAR T-Cell Therapy Updates

about 5 years ago

Article

ASH 2020: The Next Wave

about 5 years ago

Article

2020 SABCS: Topics in Precision Oncology

about 5 years ago

Article

Lauren M. Corduck, Founder of Oneinforty, Dies at 49; Advocated for Change in BRCA Testing Guidelines

about 5 years ago

peer-reviewed

Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

about 5 years ago

peer-reviewed

Clinical and Economic Burden of Intravenous Paclitaxel or nab-Paclitaxel for Metastatic Breast Cancer

about 5 years ago

peer-reviewed

Supplemental Material: Clinical and Economic Burden of Intravenous Paclitaxel or nab-Paclitaxel for Metastatic Breast Cancer

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Patient Advocacy Helps Shape Clinical Trial Approvals, Policy Decisions: Debra Patt, MD, PhD, MBA, MPH

ByBrooke McCormick,Debra Patt, MD, PhD, MBA, MPH

January 16th 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Patient Perspectives Drive More Relevant, Feasible Clinical Research: Debra Patt, MD, PhD, MBA, MPH

ByBrooke McCormick,Debra Patt, MD, PhD, MBA, MPH

January 13th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Articles in this issue

Newsletter

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Patient Advocacy Helps Shape Clinical Trial Approvals, Policy Decisions: Debra Patt, MD, PhD, MBA, MPH

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Patient Perspectives Drive More Relevant, Feasible Clinical Research: Debra Patt, MD, PhD, MBA, MPH

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Novel CLL Therapies Prompt New Treatment Considerations

Congress Unveils Massive Funding Bill to Avert Shutdown

Early Data Show Feasibility of in Vivo CAR T Therapy in Multiple Myeloma

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care